BioWorld Asia

Sep. 22, 2004

BMS Drops Flamel’s Basulin; Shares Suffer 22 Percent Hit

It may be true that “two out of three ain’t bad” - but two pieces of good news and one seriously negative item added up to trouble on Wall Street for Flamel Technologies SA. (BioWorld International) Read More

Acambis Falls On Cancelled Smallpox Contract From CDC

Angiogenesis Study Turns Up Male Infertility Surprise Factor

CeNeS Reports Positive Phase III M6G Data In Post-Operative Pain

Active Biotech Seeking SEK150M In Convertible Debentures Issue

Genetic Markers Of Epidermis Cell Differentiation Identified

Novagali Pharma Completes Second Round For EUR14.2M

EU Medicines Guidelines Up For General Comment

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 23, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

Nankai University and Accendatech present new majusculamide D derivatives

BioWorld Science

Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...